Drugs for HER-2-positive breast cancer
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...
Na minha lista:
Main Authors: | , , , |
---|---|
Format: | Livro |
Sprog: | Inglês |
Udgivet: |
Springer,
2011
|
Serier: | Milestones in Drug Therapy, |
Fag: | |
Online adgang: | https://minerva.ufrj.br/F/?func=direct&doc_number=000895504&local_base=UFR01 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|